Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,701,745
+$5,125,419 QoQ
Shares Held
2,646,197
+57.2% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Derivatives in ABUS
reported options exposure · as of Dec 31, 2021CallValue
$1,963,672
CallShares
504,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ABUS ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ABUS
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,701,745 | 2,646,197 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,576,326 | 1,683,628 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $8,815,305 | 1,832,704 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,586,731 | 1,450,822 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,700,752 | 1,197,655 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,599,208 | 458,226 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,181,462 | 361,304 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $729,181 | 189,398 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $257,324 | 83,277 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $176,634 | 68,463 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $229,877 | 91,951 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $184,242 | 90,760 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $256,500 | 111,522 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $266,569 | 87,977 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $173,062 | 74,276 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $105,400 | 55,184 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $104,215 | 38,456 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $142,333 | 47,763 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,963,672 | 504,800 | Call | Defined | 2022-02-08 | |
| 2021-12-31 | $2,750,605 | 707,097 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $217,074 | 50,600 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $2,645,148 | 616,585 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $5,242,380 | 1,222,000 | Call | Defined | 2021-11-15 | |
| 2021-06-30 | $266,640 | 88,000 | Call | Defined | 2021-09-13 | |
| 2021-06-30 | $1,052,572 | 347,384 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $266,640 | 88,000 | Put | Defined | 2021-09-13 | |
| 2021-03-31 | $1,252,904 | 376,248 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $17,870 | 5,034 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $9,393 | 3,001 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $99,370 | 54,599 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $55,093 | 54,549 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||